Atara Biotherapeutics, Inc.

Q1 2022 vs. Q2 2022 13F Holders

Period
Q1 2022
Q2 2022
Num holders
152
138
Total reported value, excl. options
$910 M
$777 M
Total shares, excl. options
97,904,316
99,795,455
Manager Q1 2022
Shares
Q2 2022
Shares
Diff Chg %